Literature DB >> 11193795

The mitochondrial spiral. An adequate cause of dementia in the Alzheimer's syndrome.

J P Blass1.   

Abstract

A variety of chronic, relatively low-grade injuries to the brain occur in Alzheimer's disease (AD). The extent to which each of these contributes to the clinical syndrome is unclear. Several of the abnormalities that occur in AD brain can cause dementia by themselves, even in people who do not have the neuropathological hallmarks of AD. Prominent among these abnormalities is a deleterious "mitochondrial spiral," which consists of reduced brain metabolism, oxidative stress, and calcium dysregulation. The hypothesis presented in this paper is that the mitochondrial spiral contributes to dementia in AD and presents a reasonable target for the development of new approaches to the treatment of this syndrome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11193795     DOI: 10.1111/j.1749-6632.2000.tb05576.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  49 in total

1.  Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.

Authors:  Baiyang Sheng; Xinglong Wang; Bo Su; Hyoung-gon Lee; Gemma Casadesus; George Perry; Xiongwei Zhu
Journal:  J Neurochem       Date:  2011-12-08       Impact factor: 5.372

2.  Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer's disease.

Authors:  Cunlu Xu; Zhenhua Wang; Ming Fan; Bing Liu; Ming Song; Xiantong Zhen; Tianzi Jiang
Journal:  Neuroreport       Date:  2010-08-23       Impact factor: 1.837

3.  Differentiated effect of ageing on the enzymes of Krebs' cycle, electron transfer complexes and glutamate metabolism of non-synaptic and intra-synaptic mitochondria from cerebral cortex.

Authors:  R F Villa; A Gorini; S Hoyer
Journal:  J Neural Transm (Vienna)       Date:  2006-09-14       Impact factor: 3.575

Review 4.  Mitochondrial regulation of neuronal plasticity.

Authors:  Mark P Mattson
Journal:  Neurochem Res       Date:  2006-10-06       Impact factor: 3.996

Review 5.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

6.  Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease.

Authors:  Heng Du; Lan Guo; Fang Fang; Doris Chen; Alexander A Sosunov; Guy M McKhann; Yilin Yan; Chunyu Wang; Hong Zhang; Jeffery D Molkentin; Frank J Gunn-Moore; Jean Paul Vonsattel; Ottavio Arancio; John Xi Chen; Shi Du Yan
Journal:  Nat Med       Date:  2008-09-21       Impact factor: 53.440

Review 7.  Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.

Authors:  Lisa Mosconi; Alberto Pupi; Mony J De Leon
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

8.  Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide.

Authors:  Mark A Lovell; Shuling Xiong; William R Markesbery; Bert C Lynn
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

9.  Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage.

Authors:  Maria Manczak; Byung S Park; Youngsin Jung; P Hemachandra Reddy
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

10.  Transcriptional regulation of insulin-degrading enzyme modulates mitochondrial amyloid β (Aβ) peptide catabolism and functionality.

Authors:  María C Leal; Natalia Magnani; Sergio Villordo; Cristina Marino Buslje; Pablo Evelson; Eduardo M Castaño; Laura Morelli
Journal:  J Biol Chem       Date:  2013-03-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.